This study looks at whether older adults with HIV (aged 60+) can safely switch from their current three-drug pill to a simpler two-drug pill. About 240 participants in Kenya will take the new pill for 96 weeks. The main goal is to check if the virus stays under control.
Phase: PHASE3 • Sponsor: University of Nairobi • Aim: Disease control
Last updated May 03, 2026 19:15 UTC